Renal Transplantation in a patient with Recessive Dystrophic Epidermolysis Bullosa: a case report
DOI:
https://doi.org/10.31053/1853.0605.v75.n1.17153Keywords:
epidermolysis bullosa, epidermolysis bullosa dystrophica, kidney transplantation.Abstract
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genodermatosis characterized by abnormalities in the anchoring fibrils which attach the basal cell layer of the epidermis to the underlying structures. A characteristic feature of this disorder is the presence of recurrent blistering or erosions, the result of even minor traction to these tissues. Patients with RDEB frequently develop chronic renal failure, and require renal replacement therapy being a major cause of morbidity and mortality. The role of renal transplantation in these patients is scarcely known.
We present the case of an end-stage renal disease patient with RDEB treated by renal transplantation and his follow-up during a period of 83 months after the transplant. In this period, there were very low frequency of serious infections as well as the absence of skin tumors.
Renal transplantation could be an alternative to renal replacement therapy in epidermolysis bullosa patients with end-stage renal disease, reducing the comorbidities associated with this treatment.
Downloads
References
LeBleu VS, Macdonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med (Maywood). 2007;232(9):1121-29.
Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58(6):931-50.
Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006. J Am Acad Dermatol. 2009;60(2):203-11.
Fine JD, Johnson LB, Weiner M, Stein A, Cash S, et al. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry. Am J Kidney Dis. 2004;44(4):651-60.
Ungureanu S, Adni T, Brown T, Inston N, Heagerty A. Successful renal transplant in a patient with non-Herlitz junctional epidermolysis bullosa. Clin Exp Dermatol. 2014;39(3):330-2.
Marinkovich MP. Inherited Epidermolysis Bullosa. In: Fitzpatrick’s Dermatology in General Medicine. 8th ed. United State of America: Mc Graw Hill; 2012. P. 649-65.
Boeira VL, Souza ES, Rocha Bde O, Oliveira PD, Oliveira Mde F, et al. Inherited epidermolysis bullosa: clinical and therapeutic aspects. An Bras Dermatol. 2013;88(2):185-98.
Castello M, Gregorini M, Rampino T, Bosio F, Bedino G, et al. A retrospective analysis of dermatological lesions in kidney transplant patients. Indian J Med Res. 2013;137(6):1188-92.
Zamanian A, Mahjub H, Mehralian A. Skin diseases in kidney transplant recipients. Urol J. 2006;3(4):230-3.
Bergfelt L, Larko O, Blohmé I. Skin disease in immunosuppressed patients in relation to epidermal Langerhans’ cells. Acta Derm Venereol. 1993;73(5):330-4.
Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, et al. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 2007;71(12):1271-8.
Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4(6):905-13.
Ulrich C, Arnold R, Frei U, Hetzer R, Neuhaus P, et al. Skin changes following organ transplantation: an interdisciplinary challenge. Dtsch Arztebl Int. 2014;111(11):188-94.
Buonocore SD, Ariyan S. Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients. Ann Plast Surg. 2009;63(3):297-9.
Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363(7):629-39.
Downloads
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
